Digestive comfort
Small trials of a defined serum-derived preparation report reduced stool frequency and improved symptom scores in chronic diarrhoea and in diarrhoea-predominant irritable bowel syndrome. The trials are small, several are open-label, and the results belong to the medical-food preparation rather than to retail IgG powder.
What may be going on: Immunoglobulins bind microbial antigens and toxins within the gut lumen without needing to be absorbed, which is a rare instance of a supplement mechanism that does not depend on crossing the gut wall.
Limited evidence. Early human work, or mostly lab and animal research.
View the 4 sources
- Treatment of enterotoxigenic and enteropathogenic Escherichia coli-induced diarrhoea in children with bovine immunoglobulin milk concentrate from hyperimmunized cows: a double-blind, placebo-controlled, clinical trial.(opens in a new tab)
Randomised controlled trial · Scandinavian journal of gastroenterology · 2000 · PMID 10972174
- Evaluation of oral serum-derived bovine immunoglobulins in HIV-infected patients with chronic idiopathic diarrhea.(opens in a new tab)
Unclassified · HIV clinical trials · 2017 · PMID 29210625
- Oral serum-derived bovine immunoglobulin improves duodenal immune reconstitution and absorption function in patients with HIV enteropathy.(opens in a new tab)
Clinical trial · AIDS (London, England) · 2013 · PMID 23660579
- Bovine immunoglobulin concentrate-clostridium difficile retains C difficile toxin neutralising activity after passage through the human stomach and small intestine.(opens in a new tab)
Clinical trial · Gut · 1999 · PMID 9895380
Deep research mode adds each paper’s own conclusion and stated limitations.